Bioforce Announces American Botanical Council Applauds Our New Echinaforce® Study

In the largest clinical trial ever conducted on the popular medicinal herb echinacea, British researchers have concluded that a special Swiss echinacea extract Echinaforce® is both safe and effective in promoting healthy immune response

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

(PRWEB) October 25, 2012

Researchers tested 755* healthy people to see if the use of an extract of echinacea root and herb was safe and effective in over a 4-month period. The randomized, double-blind, placebo-controlled clinical trial used Echinaforce®, an alcoholic extract of the leaves (95%) and roots (5%) of organically grown Echinacea (Echinacea purpurea). (Echinaforce is made by Bioforce AG in Roggwill, Switzerland, and imported into the United States by Bioforce USA in Ghent, New York.)

The study took place at the Common Cold Center at Cardiff University in Cardiff, Wales, of the United Kingdom. It is not only the largest Echinacea study, but also the first to use viral analytics. An important conclusion of this new study along with its effectiveness is that even after using Echinaforce for 4 months, any adverse effects were mild, and because the adverse effects experienced with the Echinacea extract were observed to be similar to those in the placebo group, the safety of Echinaforce was evaluated as high. This is consistent with the safety of other Echinacea preparations in additional published clinical trials as well as the documented general safety of many Echinacea products in general use.

“It is heartening and refreshing to see such positive conclusions coming from this largest Echinacea clinical trial ever published,” said Mark Blumenthal, founder and executive director of the American Botanical Council. “While there have been previous clinical studies producing mixed results on the efficacy of various types of Echinacea preparations, used at different dosage levels, and in different types of study design, this highly impressive clinical trial is historic due to its size. It employed a high-quality, well-researched Echinacea product, a credible study design, and had enough people to produce statistically significant positive results.”

According to Pierce Sioussat, president of Bioforce USA “the excellent results obtained are due to the unique properties of Echinaforce®. Echinaforce® is made from fresh, organic Echinacea purpurea plants grown by Bioforce, including both plant and root. Bioforce’s research has shown that fresh Echinacea extract has over 3 times the amount of alkylamides as extracts from dried plants. Their research has also shown that the alkylamides have a proven mode of action on the immune system. In fact, Echinaforce has 14 published studies making it the World’s Best Researched Echinacea.”

For more information contact Eileen Sheets at 800-641-7555


Contact